Spikevax
Alternative Names: Moderna COVID-19 Vaccine, mRNA-1273
The Moderna COVID-19 vaccine, brand name Spikevax, is an mRNA vaccine that teaches the body to recognize and fight the virus that causes COVID-19. It works by using a small piece of genetic code to help the immune system make antibodies against the virus’s spike protein.
Originally authorized in late 2020, the Moderna vaccine has been updated over time to protect against newer variants. It’s approved for use in adults and children, with different dosing schedules based on age and risk level. Like other COVID-19 vaccines, protection tends to decrease after about 6 months, so booster doses are recommended, especially for higher-risk groups.
Common side effects include arm soreness, tiredness, headache, and mild fever. Serious side effects are rare.
Treatment Type: Prescription Medication
Treatment Class: Vaccine
Treatment Modality: Injection
Review Summary
Based on the single expert review provided, the Moderna COVID-19 vaccine (Spikevax) is considered an effective tool in protecting against severe illness, particularly for high-risk individuals. However, the review suggests that the vaccine's protection typically wanes after about six months, and the decision to continue with updated doses should be based on personal risk factors and current public health guidance.
This summary was generated by users' reviews
Breakdown by Category
Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.
Explore various treatment options to empower yourself in making a well-informed choice.
Choose treatments from the menu above to see how they compare side by side.
Choose treatments from the menu above to see how they compare side by side.
Choose treatments from the menu above to see how they compare side by side.
5.0
AI Summary of User Experiences
Not medical advice.
Based on the single expert review provided, the Moderna COVID-19 vaccine (Spikevax) is considered an effective tool in protecting against severe illness, particularly for high-risk individuals. However, the review suggests that the vaccine's protection typically wanes after about six months, and the decision to continue with updated doses should be based on personal risk factors and current public health guidance.
Reviews
Filter by reviewer type Pro